BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27155159)

  • 1. Multiple roles of NF1 in the melanocyte lineage.
    Larribère L; Utikal J
    Pigment Cell Melanoma Res; 2016 Jul; 29(4):417-25. PubMed ID: 27155159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma.
    Mahalingam M
    Adv Anat Pathol; 2017 Jan; 24(1):1-14. PubMed ID: 27941538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NF1 gene in tumor syndromes and melanoma.
    Kiuru M; Busam KJ
    Lab Invest; 2017 Feb; 97(2):146-157. PubMed ID: 28067895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.
    Thielmann CM; Chorti E; Matull J; Murali R; Zaremba A; Lodde G; Jansen P; Richter L; Kretz J; Möller I; Sucker A; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Weichenthal M; Paschen A; Livingstone E; Zimmer L; Schadendorf D; Hadaschik E; Ugurel S; Griewank KG
    Eur J Cancer; 2021 Dec; 159():113-124. PubMed ID: 34742158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of cultured human NF1 heterozygous (NF1+/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene.
    Boucneau J; De Schepper S; Vuylsteke M; Van Hummelen P; Naeyaert JM; Lambert J
    Pigment Cell Res; 2005 Aug; 18(4):285-99. PubMed ID: 16033338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigment cell-related manifestations in neurofibromatosis type 1: an overview.
    De Schepper S; Boucneau J; Lambert J; Messiaen L; Naeyaert JM
    Pigment Cell Res; 2005 Feb; 18(1):13-24. PubMed ID: 15649148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
    Rübben A; Bausch B; Nikkels A
    Mol Cancer; 2006 Sep; 5():36. PubMed ID: 16961930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
    Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
    J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 1 (NF1) gene: Beyond café au lait spots and dermal neurofibromas.
    Peltonen S; Kallionpää RA; Peltonen J
    Exp Dermatol; 2017 Jul; 26(7):645-648. PubMed ID: 27622733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of the NF1 tumor suppressor locus in uveal melanoma.
    Foster WJ; Fuller CE; Perry A; Harbour JW
    Arch Ophthalmol; 2003 Sep; 121(9):1311-5. PubMed ID: 12963615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma Risk and Melanocyte Biology.
    Bertrand JU; Steingrimsson E; Jouenne F; Bressac-de Paillerets B; Larue L
    Acta Derm Venereol; 2020 Jun; 100(11):adv00139. PubMed ID: 32346747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
    Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
    Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver?
    Kadokura A; Frydenlund N; Leone DA; Yang S; Hoang MP; Deng A; Hernandez-Perez M; Biswas A; Singh R; Yaar R; Mahalingam M
    Hum Pathol; 2016 Jul; 53():82-90. PubMed ID: 26980030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF1 Mutations Are Common in Desmoplastic Melanoma.
    Wiesner T; Kiuru M; Scott SN; Arcila M; Halpern AC; Hollmann T; Berger MF; Busam KJ
    Am J Surg Pathol; 2015 Oct; 39(10):1357-62. PubMed ID: 26076063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of cutaneous melanocytic neoplasms.
    Ibrahim N; Haluska FG
    Annu Rev Pathol; 2009; 4():551-79. PubMed ID: 19400696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.
    Abramowicz A; Gos M
    Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NF1 somatic mutational landscape in sporadic human cancers.
    Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M
    Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model.
    Larribere L; Wu H; Novak D; Galach M; Bernhardt M; Orouji E; Weina K; Knappe N; Sachpekidis C; Umansky L; Beckhove P; Umansky V; De Schepper S; Kaufmann D; Ballotti R; Bertolotto C; Utikal J
    Pigment Cell Melanoma Res; 2015 Jul; 28(4):407-16. PubMed ID: 25824590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous neurofibromas in the genomics era: current understanding and open questions.
    Allaway RJ; Gosline SJC; La Rosa S; Knight P; Bakker A; Guinney J; Le LQ
    Br J Cancer; 2018 Jun; 118(12):1539-1548. PubMed ID: 29695767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.